TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe.
Price History & Performance
|Historical stock prices|
|Current Share Price||₹48.45|
|52 Week High||₹39.55|
|52 Week Low||₹74.60|
|1 Month Change||-6.56%|
|3 Month Change||-20.77%|
|1 Year Change||12.54%|
|3 Year Change||-69.31%|
|5 Year Change||-70.26%|
|Change since IPO||-47.78%|
Recent News & Updates
TAKE Solutions (NSE:TAKE) Is Making Moderate Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Here's Why TAKE Solutions (NSE:TAKE) Can Afford Some Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
|TAKE||IN Healthcare Services||IN Market|
Return vs Industry: TAKE exceeded the Indian Healthcare Services industry which returned -14.2% over the past year.
Return vs Market: TAKE underperformed the Indian Market which returned 61% over the past year.
Stable Share Price: TAKE is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: TAKE's weekly volatility (5%) has been stable over the past year.
About the Company
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services.
TAKE Solutions Fundamentals Summary
|TAKE fundamental statistics|
Is TAKE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TAKE income statement (TTM)|
|Cost of Revenue||₹6.55b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-14.67|
|Net Profit Margin||-26.25%|
How did TAKE perform over the long term?See historical performance and comparison
Is TAKE Solutions undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TAKE (₹48.45) is trading below our estimate of fair value (₹105.28)
Significantly Below Fair Value: TAKE is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TAKE is unprofitable, so we can't compare its PE Ratio to the Asian Healthcare Services industry average.
PE vs Market: TAKE is unprofitable, so we can't compare its PE Ratio to the Indian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TAKE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TAKE is good value based on its PB Ratio (0.6x) compared to the XA Healthcare Services industry average (4.7x).
How is TAKE Solutions forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TAKE Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has TAKE Solutions performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TAKE is currently unprofitable.
Growing Profit Margin: TAKE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TAKE is unprofitable, and losses have increased over the past 5 years at a rate of 53.9% per year.
Accelerating Growth: Unable to compare TAKE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TAKE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (55.8%).
Return on Equity
High ROE: TAKE has a negative Return on Equity (-19.09%), as it is currently unprofitable.
How is TAKE Solutions's financial position?
Financial Position Analysis
Short Term Liabilities: TAKE's short term assets (₹8.6B) exceed its short term liabilities (₹5.2B).
Long Term Liabilities: TAKE's short term assets (₹8.6B) exceed its long term liabilities (₹2.0B).
Debt to Equity History and Analysis
Debt Level: TAKE's debt to equity ratio (48.9%) is considered high.
Reducing Debt: TAKE's debt to equity ratio has reduced from 49.7% to 48.9% over the past 5 years.
Debt Coverage: TAKE's debt is well covered by operating cash flow (24.6%).
Interest Coverage: Insufficient data to determine if TAKE's interest payments on its debt are well covered by EBIT.
What is TAKE Solutions's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TAKE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TAKE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TAKE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TAKE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: TAKE is not paying a notable dividend for the Indian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TAKE's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Harikesavanallur Srinivasan (57 yo)
Mr. Harikesavanallur Ramani Srinivasan co-founded Take Solutions Ltd. in 2000 and has been its Managing Director since April 1, 2013. Mr. Srinivasan serves as the President of Chennai - India of The Indus...
CEO Compensation Analysis
Compensation vs Market: Harikesavanallur's total compensation ($USD292.66K) is above average for companies of similar size in the Indian market ($USD38.82K).
Compensation vs Earnings: Harikesavanallur's compensation has increased whilst the company is unprofitable.
Experienced Management: TAKE's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: TAKE's board of directors are considered experienced (6.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
TAKE Solutions Limited's employee growth, exchange listings and data sources
- Name: TAKE Solutions Limited
- Ticker: TAKE
- Exchange: NSEI
- Founded: 2000
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: ₹7.085b
- Shares outstanding: 146.22m
- Website: https://www.takesolutions.com
Number of Employees
- TAKE Solutions Limited
- No. 27, Tank Bund Road
- Tamil Nadu
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 16:49|
|End of Day Share Price||2021/10/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.